Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Sarepta Therapeutics, Inc. (SRPT) had Weighted-Average Shares Outstanding (Basic) of 100.12M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.20B |
|
$-713.41M |
|
$839.61M |
|
$1.36B |
|
$2.90B |
|
$-699.78M |
|
$-2.44M |
|
$-702.23M |
|
$-702.23M |
|
$-713.41M |
|
$-713.41M |
|
$-713.41M |
|
$-713.41M |
|
$-699.78M |
|
$-699.78M |
|
|
Weighted-Average Shares Outstanding (Basic) |
100.12M |
100.12M |
|
$-7.13 |
|
$-7.13 |
|
| Balance Sheet Financials | |
$2.54B |
|
$345.12M |
|
$811.76M |
|
$3.35B |
|
$1.10B |
|
$828.97M |
|
$1.11B |
|
$2.21B |
|
$1.14B |
|
$1.14B |
|
$1.14B |
|
104.96M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|